The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide Indictment of Osteopathic Physician Signals Shift in Peptide Enforcement Stevens & Lee Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Canada.ca Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences FDA Moves to Reevaluate Several Peptides American Med Spa Association